1. Home
  2. AKBA vs OVBC Comparison

AKBA vs OVBC Comparison

Compare AKBA & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.59

Market Cap

248.3M

Sector

Health Care

ML Signal

HOLD

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$45.85

Market Cap

220.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
OVBC
Founded
2007
1872
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
248.3M
220.0M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
AKBA
OVBC
Price
$0.59
$45.85
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $3.92
N/A
AVG Volume (30 Days)
★ 6.4M
14.5K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 2.18%
EPS Growth
★ 93.94
42.67
EPS
N/A
★ 1.53
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$30.20
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$34.18
52 Week High
$3.19
$51.25

Technical Indicators

Market Signals
Indicator
AKBA
OVBC
Relative Strength Index (RSI) 20.35 54.62
Support Level N/A $45.25
Resistance Level $0.98 $46.52
Average True Range (ATR) 0.05 0.87
MACD -0.02 0.07
Stochastic Oscillator 4.44 62.33

Price Performance

Historical Comparison
AKBA
OVBC

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

Share on Social Networks: